ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesK22.70

K22.70

Billable

Barrett's esophagus without dysplasia

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/06/2025

Code Description

ICD-10 K22.70 is a billable code used to indicate a diagnosis of barrett's esophagus without dysplasia.

Key Diagnostic Point:

Barrett's esophagus is a condition in which the normal squamous cells lining the esophagus are replaced by columnar cells, a process known as intestinal metaplasia. This change is often a result of chronic gastroesophageal reflux disease (GERD), where stomach acid frequently flows back into the esophagus, causing irritation and damage. Clinically, patients may present with symptoms such as heartburn, regurgitation, and difficulty swallowing, although some may be asymptomatic. The anatomy involved includes the lower esophagus, where the transition from squamous to columnar epithelium occurs. Disease progression can lead to dysplasia, which is a precancerous condition, but K22.70 specifically refers to Barrett's esophagus without dysplasia, indicating that while the cellular changes are present, they have not progressed to a more severe form. Diagnostic considerations typically involve endoscopy and biopsy to confirm the presence of Barrett's esophagus and rule out dysplasia or malignancy. Regular monitoring is essential due to the increased risk of esophageal adenocarcinoma associated with Barrett's esophagus.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Diagnostic complexity: Requires endoscopic evaluation and histological confirmation.
  • Treatment complexity: Management may involve lifestyle modifications, pharmacotherapy, or surveillance.
  • Documentation requirements: Detailed clinical history and endoscopic findings must be documented.
  • Coding specificity: Requires accurate coding to differentiate from Barrett's esophagus with dysplasia.

Audit Risk Factors

  • Common coding errors: Misclassification of Barrett's esophagus with dysplasia.
  • Documentation gaps: Incomplete endoscopic reports or lack of biopsy results.
  • Billing challenges: Potential denials if documentation does not clearly support the diagnosis.

Specialty Focus

Medical Specialties

Gastroenterology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Oncology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related ICD-10 Codes

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

Barrett's esophagus has significant clinical implications due to its association with an increased risk of esophageal adenocarcinoma. Understanding the prevalence of Barrett's esophagus in the population, particularly among patients with chronic GERD, is crucial for early detection and management. Quality measures may include regular surveillance endoscopies to monitor for dysplastic changes, which can improve patient outcomes and reduce healthcare utilization related to advanced esophageal cancer.

ICD-9 vs ICD-10

Barrett's esophagus has significant clinical implications due to its association with an increased risk of esophageal adenocarcinoma. Understanding the prevalence of Barrett's esophagus in the population, particularly among patients with chronic GERD, is crucial for early detection and management. Quality measures may include regular surveillance endoscopies to monitor for dysplastic changes, which can improve patient outcomes and reduce healthcare utilization related to advanced esophageal cancer.

Reimbursement & Billing Impact

Reimbursement considerations include ensuring that the endoscopy and biopsy procedures are appropriately coded and that the medical necessity is clearly documented. Common denials may arise from insufficient documentation or failure to provide evidence of the absence of dysplasia. Best practices include maintaining thorough records of patient history, symptoms, and results from diagnostic procedures to support the claim.

Resources

Clinical References

  • •
    ICD-10 Official Guidelines for K00-K99
  • •
    Clinical Documentation Requirements

Coding & Billing References

  • •
    ICD-10 Official Guidelines for K00-K99
  • •
    Clinical Documentation Requirements

Frequently Asked Questions

What specific conditions are covered by K22.70?

K22.70 covers Barrett's esophagus without dysplasia, characterized by intestinal metaplasia of the esophageal lining without any precancerous cellular changes.

When should K22.70 be used instead of related codes?

K22.70 should be used when the diagnosis of Barrett's esophagus is confirmed without any evidence of dysplasia, differentiating it from codes that indicate dysplastic changes.

What documentation supports K22.70?

Documentation must include endoscopic findings, biopsy results confirming intestinal metaplasia, and a clear statement that dysplasia is absent.